HTR2A and ANKS1B |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
ankyrin repeat and sterile alpha motif domain containing 1B |
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- G alpha (q) signalling events
- G alpha (q) signalling events
- Signaling by GPCR
- GPCR downstream signaling
- Gastrin-CREB signalling pathway via PKC and MAPK
- Class A/1 (Rhodopsin-like receptors)
- Amine ligand-binding receptors
- Metabolic disorders of biological oxidation enzymes
- GPCR ligand binding
- Serotonin receptors
|
|
- Ziprasidone
- Methysergide
- Cabergoline
- Ropinirole
- Amitriptyline
- Olanzapine
- Clozapine
- Mirtazapine
- Loxapine
- Remoxipride
- Pramipexole
- Promazine
- Cyproheptadine
- Imipramine
- Chlorpromazine
- Haloperidol
- Nortriptyline
- Lisuride
- Cisapride
- Trazodone
- Thioridazine
- Ergotamine
- Apomorphine
- Paroxetine
- Trimipramine
- Risperidone
- Epinastine
- Propiomazine
- Minaprine
- Donepezil
- Flupenthixol
- Cyclobenzaprine
- Mesoridazine
- Promethazine
- Tegaserod
- Doxepin
- Nefazodone
- Desipramine
- Pergolide
- Bromocriptine
- Quetiapine
- Aripiprazole
- Chlorprothixene
- Clomipramine
- Paliperidone
- Dihydroergotoxine
- Yohimbine
- Methotrimeprazine
- MMDA
- 3,4-Methylenedioxymethamphetamine
- Dimethyltryptamine
- Acepromazine
- Molindone
- Pipotiazine
- Thioproperazine
- Thiothixene
- Zuclopenthixol
- Aniracetam
- Fluspirilene
- Iloperidone
- Sertindole
- Mianserin
- Asenapine
- Amisulpride
- Cinitapride
- Lurasidone
|
|
|
|
HTR2A and NTRK3 |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
neurotrophic tyrosine kinase, receptor, type 3 |
- Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
- G alpha (q) signalling events
- G alpha (q) signalling events
- Signaling by GPCR
- GPCR downstream signaling
- Gastrin-CREB signalling pathway via PKC and MAPK
- Class A/1 (Rhodopsin-like receptors)
- Amine ligand-binding receptors
- Metabolic disorders of biological oxidation enzymes
- GPCR ligand binding
- Serotonin receptors
|
|
- Ziprasidone
- Methysergide
- Cabergoline
- Ropinirole
- Amitriptyline
- Olanzapine
- Clozapine
- Mirtazapine
- Loxapine
- Remoxipride
- Pramipexole
- Promazine
- Cyproheptadine
- Imipramine
- Chlorpromazine
- Haloperidol
- Nortriptyline
- Lisuride
- Cisapride
- Trazodone
- Thioridazine
- Ergotamine
- Apomorphine
- Paroxetine
- Trimipramine
- Risperidone
- Epinastine
- Propiomazine
- Minaprine
- Donepezil
- Flupenthixol
- Cyclobenzaprine
- Mesoridazine
- Promethazine
- Tegaserod
- Doxepin
- Nefazodone
- Desipramine
- Pergolide
- Bromocriptine
- Quetiapine
- Aripiprazole
- Chlorprothixene
- Clomipramine
- Paliperidone
- Dihydroergotoxine
- Yohimbine
- Methotrimeprazine
- MMDA
- 3,4-Methylenedioxymethamphetamine
- Dimethyltryptamine
- Acepromazine
- Molindone
- Pipotiazine
- Thioproperazine
- Thiothixene
- Zuclopenthixol
- Aniracetam
- Fluspirilene
- Iloperidone
- Sertindole
- Mianserin
- Asenapine
- Amisulpride
- Cinitapride
- Lurasidone
|
|
|
|
DCP2 and DCP1B |
decapping mRNA 2 |
decapping mRNA 1B |
- Regulation of mRNA stability by proteins that bind AU-rich elements
- KSRP destabilizes mRNA
- ATF4 activates genes
- mRNA decay by 5' to 3' exoribonuclease
- Tristetraprolin (TTP) destabilizes mRNA
- PERK regulates gene expression
- Unfolded Protein Response (UPR)
- Deadenylation-dependent mRNA decay
- Butyrate Response Factor 1 (BRF1) destabilizes mRNA
|
- mRNA decay by 5' to 3' exoribonuclease
- Deadenylation-dependent mRNA decay
|
|
|
|
|
IRF8 and NFKB1 |
interferon regulatory factor 8 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
- Interferon gamma signaling
- Interferon Signaling
- Cytokine Signaling in Immune system
- Interferon alpha/beta signaling
|
- Signaling by the B Cell Receptor (BCR)
- NF-kB is activated and signals survival
- Downstream TCR signaling
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Cellular Senescence
- RIP-mediated NFkB activation via ZBP1
- Toll Like Receptor TLR6:TLR2 Cascade
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- Activated TLR4 signalling
- Toll Like Receptor TLR1:TLR2 Cascade
- Downstream signaling events of B Cell Receptor (BCR)
- FCERI mediated NF-kB activation
- MyD88 cascade initiated on plasma membrane
- Toll Like Receptor 5 (TLR5) Cascade
- ZBP1(DAI) mediated induction of type I IFNs
- p75NTR signals via NF-kB
- Transcriptional regulation of white adipocyte differentiation
- MyD88 dependent cascade initiated on endosome
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88:Mal cascade initiated on plasma membrane
- Toll Like Receptor 9 (TLR9) Cascade
- Innate Immune System
- Regulated proteolysis of p75NTR
- Signalling by NGF
- TRIF-mediated TLR3/TLR4 signaling
- Cytosolic sensors of pathogen-associated DNA
- Senescence-Associated Secretory Phenotype (SASP)
- Cytokine Signaling in Immune system
- p75 NTR receptor-mediated signalling
- MyD88-independent cascade
- Toll Like Receptor 2 (TLR2) Cascade
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Signaling by Interleukins
- TCR signaling
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Interleukin-1 processing
- Toll Like Receptor 3 (TLR3) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- Activation of NF-kappaB in B cells
- Fc epsilon receptor (FCERI) signaling
- TRAF6 mediated NF-kB activation
- Interleukin-1 signaling
- Adaptive Immune System
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
|
- Thalidomide
- Pranlukast
- Triflusal
|
|
|
ID1 and TCF4 |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein |
transcription factor 4 |
- Cellular Senescence
- Oncogene Induced Senescence
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
ID2 and TCF4 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
transcription factor 4 |
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
ID3 and TCF4 |
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
transcription factor 4 |
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
ID4 and TCF4 |
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
transcription factor 4 |
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
IFRD1 and HDAC4 |
interferon-related developmental regulator 1 |
histone deacetylase 4 |
|
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by NOTCH1
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- FBXW7 Mutants and NOTCH1 in Cancer
|
|
|
|
|
IGF2 and BAG6 |
insulin-like growth factor 2 |
BCL2-associated athanogene 6 |
- IRS-related events triggered by IGF1R
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Response to elevated platelet cytosolic Ca2+
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- SHC-related events triggered by IGF1R
- Platelet degranulation
- Platelet activation, signaling and aggregation
- IGF1R signaling cascade
|
|
|
|
|
|
IGFBP5 and BAG6 |
insulin-like growth factor binding protein 5 |
BCL2-associated athanogene 6 |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
|
|
|
|
|
RBPJ and NOTCH4 |
recombination signal binding protein for immunoglobulin kappa J region |
notch 4 |
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- Signaling by NOTCH
- NOTCH2 intracellular domain regulates transcription
- Notch-HLH transcription pathway
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by NOTCH2
- Regulation of beta-cell development
- Generic Transcription Pathway
- Pre-NOTCH Transcription and Translation
- Signaling by NOTCH1
- Pre-NOTCH Expression and Processing
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- FBXW7 Mutants and NOTCH1 in Cancer
|
- Notch-HLH transcription pathway
- Signaling by NOTCH4
- Generic Transcription Pathway
- Pre-NOTCH Processing in Golgi
- Pre-NOTCH Transcription and Translation
- Signaling by NOTCH
- Pre-NOTCH Processing in the Endoplasmic Reticulum
- Pre-NOTCH Expression and Processing
|
|
|
|
|
IKBKB and NFKB1 |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
- Signaling by the B Cell Receptor (BCR)
- NF-kB is activated and signals survival
- RIP-mediated NFkB activation via ZBP1
- IRAK1 recruits IKK complex
- Downstream signaling events of B Cell Receptor (BCR)
- Toll Like Receptor TLR1:TLR2 Cascade
- FCERI mediated NF-kB activation
- Toll Like Receptor 5 (TLR5) Cascade
- NOD1/2 Signaling Pathway
- MyD88 dependent cascade initiated on endosome
- Toll Like Receptor 9 (TLR9) Cascade
- IRAK1 recruits IKK complex
- TRIF-mediated TLR3/TLR4 signaling
- Toll Like Receptor 2 (TLR2) Cascade
- TCR signaling
- Signaling by Interleukins
- Toll Like Receptor 4 (TLR4) Cascade
- Toll Like Receptor 3 (TLR3) Cascade
- Fc epsilon receptor (FCERI) signaling
- Interleukin-1 signaling
- Adaptive Immune System
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- Downstream TCR signaling
- p75NTR recruits signalling complexes
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Toll Like Receptor TLR6:TLR2 Cascade
- Activated TLR4 signalling
- MyD88 cascade initiated on plasma membrane
- ZBP1(DAI) mediated induction of type I IFNs
- p75NTR signals via NF-kB
- MyD88:Mal cascade initiated on plasma membrane
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- Innate Immune System
- Signalling by NGF
- IKK complex recruitment mediated by RIP1
- Cytosolic sensors of pathogen-associated DNA
- p75 NTR receptor-mediated signalling
- Cytokine Signaling in Immune system
- MyD88-independent cascade
- Toll-Like Receptors Cascades
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Toll Like Receptor 10 (TLR10) Cascade
- Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
- Activation of NF-kappaB in B cells
- TRAF6 mediated NF-kB activation
- NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
- IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
|
- Signaling by the B Cell Receptor (BCR)
- NF-kB is activated and signals survival
- Downstream TCR signaling
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Cellular Senescence
- RIP-mediated NFkB activation via ZBP1
- Toll Like Receptor TLR6:TLR2 Cascade
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- Activated TLR4 signalling
- Toll Like Receptor TLR1:TLR2 Cascade
- Downstream signaling events of B Cell Receptor (BCR)
- FCERI mediated NF-kB activation
- MyD88 cascade initiated on plasma membrane
- Toll Like Receptor 5 (TLR5) Cascade
- ZBP1(DAI) mediated induction of type I IFNs
- p75NTR signals via NF-kB
- Transcriptional regulation of white adipocyte differentiation
- MyD88 dependent cascade initiated on endosome
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88:Mal cascade initiated on plasma membrane
- Toll Like Receptor 9 (TLR9) Cascade
- Innate Immune System
- Regulated proteolysis of p75NTR
- Signalling by NGF
- TRIF-mediated TLR3/TLR4 signaling
- Cytosolic sensors of pathogen-associated DNA
- Senescence-Associated Secretory Phenotype (SASP)
- Cytokine Signaling in Immune system
- p75 NTR receptor-mediated signalling
- MyD88-independent cascade
- Toll Like Receptor 2 (TLR2) Cascade
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Signaling by Interleukins
- TCR signaling
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Interleukin-1 processing
- Toll Like Receptor 3 (TLR3) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- Activation of NF-kappaB in B cells
- Fc epsilon receptor (FCERI) signaling
- TRAF6 mediated NF-kB activation
- Interleukin-1 signaling
- Adaptive Immune System
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
- Mesalazine
- Sulfasalazine
- Auranofin
- Arsenic trioxide
|
- Thalidomide
- Pranlukast
- Triflusal
|
|
|
IL1A and IL1R2 |
interleukin 1, alpha |
interleukin 1 receptor, type II |
- Signaling by Interleukins
- Interleukin-1 processing
- Cellular Senescence
- Interleukin-1 signaling
- Senescence-Associated Secretory Phenotype (SASP)
- Cytokine Signaling in Immune system
|
- Signaling by Interleukins
- Cytokine Signaling in Immune system
- Interleukin-1 signaling
|
|
|
|
|
IL1B and IL1R2 |
interleukin 1, beta |
interleukin 1 receptor, type II |
- Signaling by Interleukins
- Interleukin-1 processing
- Interleukin-1 signaling
- Cytokine Signaling in Immune system
|
- Signaling by Interleukins
- Cytokine Signaling in Immune system
- Interleukin-1 signaling
|
- Minocycline
- Gallium nitrate
- Canakinumab
- Rilonacept
|
|
|
|
IL1RAP and IL1R2 |
interleukin 1 receptor accessory protein |
interleukin 1 receptor, type II |
|
- Signaling by Interleukins
- Cytokine Signaling in Immune system
- Interleukin-1 signaling
|
|
|
|
|
IL1RN and IL1R2 |
interleukin 1 receptor antagonist |
interleukin 1 receptor, type II |
- Signaling by Interleukins
- Cytokine Signaling in Immune system
- Interleukin-1 signaling
|
- Signaling by Interleukins
- Cytokine Signaling in Immune system
- Interleukin-1 signaling
|
|
|
|
|
IL2RA and NFKB1 |
interleukin 2 receptor, alpha |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- Signaling by Interleukins
- GPCR downstream signaling
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
- Signaling by the B Cell Receptor (BCR)
- NF-kB is activated and signals survival
- Downstream TCR signaling
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Cellular Senescence
- RIP-mediated NFkB activation via ZBP1
- Toll Like Receptor TLR6:TLR2 Cascade
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- Activated TLR4 signalling
- Toll Like Receptor TLR1:TLR2 Cascade
- Downstream signaling events of B Cell Receptor (BCR)
- FCERI mediated NF-kB activation
- MyD88 cascade initiated on plasma membrane
- Toll Like Receptor 5 (TLR5) Cascade
- ZBP1(DAI) mediated induction of type I IFNs
- p75NTR signals via NF-kB
- Transcriptional regulation of white adipocyte differentiation
- MyD88 dependent cascade initiated on endosome
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88:Mal cascade initiated on plasma membrane
- Toll Like Receptor 9 (TLR9) Cascade
- Innate Immune System
- Regulated proteolysis of p75NTR
- Signalling by NGF
- TRIF-mediated TLR3/TLR4 signaling
- Cytosolic sensors of pathogen-associated DNA
- Senescence-Associated Secretory Phenotype (SASP)
- Cytokine Signaling in Immune system
- p75 NTR receptor-mediated signalling
- MyD88-independent cascade
- Toll Like Receptor 2 (TLR2) Cascade
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Signaling by Interleukins
- TCR signaling
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Interleukin-1 processing
- Toll Like Receptor 3 (TLR3) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- Activation of NF-kappaB in B cells
- Fc epsilon receptor (FCERI) signaling
- TRAF6 mediated NF-kB activation
- Interleukin-1 signaling
- Adaptive Immune System
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
- Denileukin diftitox
- Aldesleukin
- Basiliximab
- Daclizumab
|
- Thalidomide
- Pranlukast
- Triflusal
|
|
|
IL3 and IL3RA |
interleukin 3 |
interleukin 3 receptor, alpha (low affinity) |
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- GPCR downstream signaling
- Signaling by Interleukins
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- GPCR downstream signaling
- Signaling by Interleukins
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
|
|
|
|
IL3RA and LNX1 |
interleukin 3 receptor, alpha (low affinity) |
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
- Signaling by GPCR
- G-protein beta:gamma signalling
- Cytokine Signaling in Immune system
- GPCR downstream signaling
- Signaling by Interleukins
- Interleukin receptor SHC signaling
- G beta:gamma signalling through PI3Kgamma
- Interleukin receptor SHC signaling
- GPVI-mediated activation cascade
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Interleukin-3, 5 and GM-CSF signaling
|
|
|
|
|
|